giu 08
Digg
Stumbleupon
Technorati
Delicious
condividi su Facebook

biopharma long term stock list update

 

 

trading-news is updating strong results from biopharma long term stocks list, we signal in red recent strong perfomer stock and new position takes: ANPI RECEIVE FDA CLEARENCE FOR PRODUCT CTIC SIGNS OF RECOVERY FROM 2,2 SELL OFF:  TICKER                     BUY AREA                QUOTE NOW     POSITION            DRIVER SVNT (NASDAQ)          7,10                             6,8             SHORT TERM     KRYSTEXXA NPSP (NASDAQ)          3,1 USD                         3,8             LONG TERM  STRONG CONSENSUS SCLN (NASDAQ)          2,25 USD                       2,2          LONG TERM     ZADAXIN SALES MAPP (NASDAQ)        8 USD(posts from 5/26)              PROFIT TAKED(+45%)   LEVADEX VNDA (NASDAQ)         8 USD (see old post 5/8)             PROFIT TAKED(+80%)       FANAT CLDA (NASDAQ)          15,7 USD                      12,2     LONG TERM           VILAZODONE CTIC (NASDAQ)         2,10  USD                    1,7    LONG TERM    PIXANTRONE/OPAXIO RESULTS ANPI (NASDAQ)           2  USD                        2,4           LONG TERM      OPTIOM® FDA CLEARENCE MEDX (NASDAQ)           7,5 USD                           7,2    LONG TERM   RECENT PRODUCTS RESULTS MNTA (NASDAQ)           8,9   USD                           9,4      LONG TERM   STRONG CONSENSUS ACAD (NASDAQ)         2,6 USD(see old post 5/6)   2,4         LONG TERM      BIOVAIL PACT ACOR (NASDAQ)        24 USD (see old post 5/6)      26,1          LONG TERM     FAMPRIDINE-SR BDSI (NASDAQ)                      PROFIT TAKED 6,3 (+18%)        ONSOLIS DNDN (NASDAQ)       22 USD (see old post 4/27)     25,1        LONG TERM         PROVENGE SPPI (NASDAQ)       4 USD (see ols post 5/12)         5,2      LONG TERM  ZEVALIN/FUSILEV

Fonte:
biopharma long term stock list update


 

Articoli correlati:


Nessun Commento

Nessun commento per ora.

Segui il feed dei commenti a questo post

Scrivi un commento